Showing results (2711-2720 of 3,978) with videos related to
Sort By:
Pageof 398
European Journal of Heart Failure|August 22, 2014
Effects of structured heart failure disease management on mortality and morbidity depend on patients' mood: results from the Interdisciplinary Network for Heart Failure StudyGötz Gelbrich, Stefan Störk, Sonja Kreißl-Kemmer, et al.European Journal of Heart Failure|September 3, 2014
Long-term follow-up results of the pacing to avoid cardiac enlargement (PACE) trialCheuk-Man Yu, Fang Fang, Xiu-Xia Luo, et al.European Journal of Heart Failure|August 29, 2014
Presence of perforin in endomyocardial biopsies of patients with inflammatory cardiomyopathy predicts poor outcomeFelicitas Escher, Uwe Kühl, Dirk Lassner, et al.European Journal of Heart Failure|September 22, 2020
Plasma D-dimer concentrations predicting stroke risk and rivaroxaban benefit in patients with heart failure and sinus rhythm: an analysis from the COMMANDER-HF trialJoão Pedro Ferreira, Carolyn S P Lam, Stefan D Anker, et al.European Journal of Heart Failure|May 1, 2022
The effect of cardiac resynchronization without a defibrillator on morbidity and mortality: an individual patient data meta-analysis of COMPANION and CARE-HFJohn G F Cleland, Michael R Bristow, Nicholas Freemantle, et al.European Journal of Heart Failure|May 3, 2022
Predictors of primary prevention implantable cardioverter-defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all-cause mortalityBenedikt Schrage, Lars H Lund, Lina Benson, et al.European Journal of Heart Failure|July 19, 2022
Use of guideline-recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistenceRoemer J Janse, Edouard L Fu, Ulf Dahlström, et al.European Journal of Heart Failure|May 5, 2022
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosisAldostefano Porcari, Maddalena Rossi, Francesco Cappelli, et al.European Journal of Heart Failure|July 22, 2022
Safety and efficacy of istaroxime in patients with acute heart failure-related pre-cardiogenic shock - a multicentre, randomized, double-blind, placebo-controlled, parallel group study (SEISMiC)Marco Metra, Ovidiu Chioncel, Gad Cotter, et al.European Journal of Heart Failure|July 22, 2022
Effects of steroidal mineralocorticoid receptor antagonists on acute and chronic estimated glomerular filtration rate slopes in patients with chronic heart failureMuthiah Vaduganathan, João Pedro Ferreira, Patrick Rossignol, et al.Pageof 398